Recently, there has been a significant increase in incidentally detected focal liver lesions. These lesions are found in up to one-third of individuals screened with cross-sectional imaging without any liver-related diseases or symptoms (
15,
16).
Focal hepatic lesions have various benign and malignant causes, and many are not readily characterizable in imaging studies, particularly when smaller than 1 cm. These lesions can usually be evaluated with serial follow-up imaging tests in patients without known cancer because nearly all will be benign (
17). In cancer patients, however, prompt determination of the cause (or likely cause) of such lesions may be pivotal for defining prognosis and therapy (
18). Despite extensive complete diagnostics, the precise diagnosis of focal hepatic lesions remains unclear in up to 50% of cases (
19-
21). Semaan et al. report a rate of merely 64% of correctly diagnosed lesions by CT and MRI. Studies concerning the prevalence of benign focal liver lesions present a quite heterogeneous picture due to population size, and investigation method. It is, therefore, difficult to compare different study results and apply them to routine ultrasound primary diagnostics (
22). The prevalence of liver lesions in our study was 2.3%. In the same way, Kaltenbach et al. studied the sonographic prevalence of benign focal liver lesions in hospital patients in Germany. They indicated about 15.1% of the individuals with at least one hepatic lesion (
23). The prevalence of hepatic hemangioma in various studies ranges from 0.1% to 20.0% (
24-
27). Our prevalence of 1.1% for hemangioma lies in the mid-range compared to the results of ultrasound-based studies (
26-
29). Compared to CT, MRI, and autopsy studies, which show a far higher prevalence range, our figure is in the lower third (
24,
25,
30,
31).
Concerning hemangioma, there are a comparatively large number of prevalence studies for hepatic cysts, but they also differ in study size, patient population, and diagnostic techniques. Retrospective and prospective studies based on ultrasound have reported the prevalence of hepatic cysts between 0.1% and 11.3% (
27,
29,
32,
33). We are also in the mid-range with our determined prevalence of 0.8%.
In our collective, hemangioma was the highest diagnostic hepatic lesion in ultrasonography examinations, with a higher frequency in females. Similarly Rungsinaporn and Phaisakamas reported a higher prevalence of hepatic hemangioma in women, while some other studies reported a higher prevalence of hemangioma in middle-aged or elderly patients, which was contrary to our results (
32-
34). On the contrary, Jacob et al. reported no statistically significant relationship between gender and liver lesions, which is inconsistent with the present study (
35). Studies reported an increasing prevalence of hepatic cysts with age (
7,
36-
38). Most studies have also found a gender-dependent relationship, with a higher prevalence of hepatic cysts in women (
32,
36-
38). On the contrary, the presence of liver lesions was not significantly related to age in our results. In line with our results, some studies in France and Japan indicated no statistically significant relationship between age and the presence of liver lesions (
39,
40).
In the present study, there was no statistically significant relationship between BMI and the presence of liver lesions. Hussain and Semelka in the Netherlands and Jacob et al. in England obtained similar results consistent with the present study (
2,
35). CT, MRI, or autopsy studies report much broader prevalence rates than ultrasound-based studies for liver lesions (
24,
41-
43). Our prevalence is in the mid to lower third of the range compared to CT, MRI, and autopsy studies. CT studies have reported the highest prevalence rates (
43). Ultrasound is a high-resolution, non-invasive imaging technique with high accuracy, low cost, and without side effects, which is well accepted by patients in many diagnostic situations (
3). Benign masses, on the other hand, are relatively common in the general population. Most of these lesions are cystic, and some are hemangiomas. Focal nodular hyperplasia and adenomas are rare but can produce an appearance quite similar to malignant masses, requiring careful ultrasound examination (
44).
This virtual epidemic of hepatic incidentalomas is mainly based on the constant improvement and widespread availability of radiologic technologies and their inflationary use in routine clinical work. This progress holds both opportunities and risks. On the one hand, it may result in the detection of a life-threatening lesion at an early, curable stage. On the other hand, detecting focal liver lesions may result in a harmful over-treatment of patients for whom merely follow-up or no treatment is adequate (
45).
Despite recent technical advances in modern radiology settings, a correct preoperative diagnosis of asymptomatic focal liver lesions remains challenging. This was a cross-sectional study; hence, further research is suggested, including the group and prospective studies characterized by long follow-up periods and long-term intervals that can be instrumental in identifying more variables influencing hepatic lesions. Hence, along with the determination of accuracy and justification of ultrasound efficiency, more comprehensive research concerning some variables, such as the history of oral contraceptive pills (OCP), is warranted. It is also suggested that other diagnostic tools be used along with ultrasonography to confirm diagnostic findings. As our study was conducted on outpatients with no acute or chronic hepatic diseases, like B and C viral hepatitis, biliary diseases, and cancer, the results can be powerfully generalized to the general population.
5.1. Conclusions
Hemangioma was the most common liver lesion diagnosed by ultrasound, which was reported marginally higher in females. Also, sonography is not recommended for the general population but is advisable in risk groups.